These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 12920)

  • 21. A morphanthridine derivative in schizophrenic patients -- lack of extrapyramidal symptoms.
    Angrist B; Rotrosen J; Aronson M; Gershon S
    Curr Ther Res Clin Exp; 1976 Jul; 20(1):94-8. PubMed ID: 8281
    [No Abstract]   [Full Text] [Related]  

  • 22. [The medicinal treatment of anxiety in alcoholism in the withdrawal stage (author's transl)].
    Guthy H
    MMW Munch Med Wochenschr; 1975 Aug; 117(35):1387-90. PubMed ID: 241014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficacy of kava-kava in the treatment of non-psychotic anxiety, following pretreatment with benzodiazepines.
    Malsch U; Kieser M
    Psychopharmacology (Berl); 2001 Sep; 157(3):277-83. PubMed ID: 11605083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A comparison of alprazolam and imipramine in the treatment of agoraphobia and panic disorder.
    Rizley R; Kahn RJ; McNair DM; Frankenthaler LM
    Psychopharmacol Bull; 1986; 22(1):167-72. PubMed ID: 2873609
    [No Abstract]   [Full Text] [Related]  

  • 25. [Double-blind trial treatment of anxiety with b 5833].
    Cloquette R
    Acta Psychiatr Belg; 1974 May; 74(3):317-26. PubMed ID: 4156149
    [No Abstract]   [Full Text] [Related]  

  • 26. [Study of an anxiolytic drug in infancy: clobazam].
    Guran P; Blanc A
    Ann Pediatr (Paris); 1977 May; 24(5):413-5. PubMed ID: 16211985
    [No Abstract]   [Full Text] [Related]  

  • 27. The value of self-report assessment in studies of anxiety disorders.
    Glass RM; Uhlenhuth EH; Kellner R
    J Clin Psychopharmacol; 1987 Aug; 7(4):215-21. PubMed ID: 2887588
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
    Arató M
    J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
    [No Abstract]   [Full Text] [Related]  

  • 29. [Treatment of anxious-depressive syndromes with tofizopam].
    Novotný V; Molcan J; Sipkovská E; Knoíková M
    Act Nerv Super (Praha); 1979 Oct; 21(3):152-3. PubMed ID: 42263
    [No Abstract]   [Full Text] [Related]  

  • 30. Alprazolam in older depressed inpatients.
    Pitts WM; Fann WE; Sajadi C; Snyder S
    J Clin Psychiatry; 1983 Jun; 44(6):213-5. PubMed ID: 6133850
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tofizopam in the therapy of anxious-depressive syndromes.
    Molcan J; Novotny V; Korinkova V; Konikova M
    Agressologie; 1981 Nov; 22(D):23-4. PubMed ID: 6120663
    [No Abstract]   [Full Text] [Related]  

  • 32. Buspirone, a novel nonbenzodiazepine anxiolytic.
    Kastenholz KV; Crismon ML
    Clin Pharm; 1984; 3(6):600-7. PubMed ID: 6150781
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The anxiolytic SC 48274 (AGN 2979; BTG 1501) in generalized anxiety disorder.
    Gittos MW
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Dec; 18(8):i-ii. PubMed ID: 7863012
    [No Abstract]   [Full Text] [Related]  

  • 34. [Evaluation of the usefulness and effectiveness of anxiolytic therapies in neoplastic diseases].
    Ziółko E; Knopik J; Bucior J; Foltyn W; Jastrzebska-Okoń K; Tomczyk A; Kempiński M
    Pol Merkur Lekarski; 2004 Jun; 16(96):561-4. PubMed ID: 15510897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [New anxiolytic drugs: methodological issues].
    Ginestet D; Corruble E
    Encephale; 1993; 19(6):627-37. PubMed ID: 12404782
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of lorazepam on hypertension-associated anxiety: a double-blind study.
    Hart WL; Parmley LF
    J Clin Psychiatry; 1978 Oct; 39(10 Pt 2):41-5. PubMed ID: 30767
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alprazolam in clinically anxious patients with depressed mood.
    Aden GC
    J Clin Psychiatry; 1983 Jan; 44(1):22-4. PubMed ID: 6130082
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of negative schizophrenic symptoms with alprazolam: a preliminary open-label study.
    Csernansky JG; Lombrozo L; Gulevich GD; Hollister LE
    J Clin Psychopharmacol; 1984 Dec; 4(6):349-52. PubMed ID: 6150950
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Double blind comparative clinical evaluation of a new anxiolytic agent, Zami-905: propazepam].
    Carbonell Masía DC; Calvé Pérez A
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1976; 4(6):377-86. PubMed ID: 19933
    [No Abstract]   [Full Text] [Related]  

  • 40. Efficacy and safety of a putative anxiolytic agent: ipsapirone.
    Borison RL; Albrecht JW; Diamond BI
    Psychopharmacol Bull; 1990; 26(2):207-10. PubMed ID: 1978371
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.